首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Review of diabetic studies

缩写:

ISSN:1613-6071

e-ISSN:1614-0575

IF/分区:0.0/

文章目录 更多期刊信息

共收录本刊相关文章索引378
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Pei-Wen Wang,Tsu-Kung Lin,Shao-Wen Weng et al. Pei-Wen Wang et al.
Mitochondrial dysfunction involves defective insulin secretion by pancreatic beta-cells, and insulin resistance in insulin-sensitive tissues such as muscle and adipose tissue. Mitochondria are recognized as the most important cellular sourc...
Natalia Vallianou,Angelos Evangelopoulos,Pavlos Koutalas Natalia Vallianou
Diabetic neuropathy presents a major public health problem. It is defined by the symptoms and signs of peripheral nerve dysfunction in diabetic patients, in whom other causes of neuropathy have been excluded. Pathogenetic mechanisms that ha...
Anders A F Sima,Weixian Zhang,Otto Muzik et al. Anders A F Sima et al.
Diabetic encephalopathy is a recently recognized complication in type 1 diabetes. In this review, we summarize a series of experimental results obtained longitudinally in the spontaneously type 1 diabetic BB/Wor-rat, and bringing out the be...
Lina Nordquist,John Wahren Lina Nordquist
Proinsulin C-peptide has been found to exert beneficial effects in many tissues affected by diabetic microvascular complications, including the kidneys. Glomerular hyperfiltration and microalbuminuria are early markers of diabetic nephropat...
Hideki Kamiya,Weixian Zhang,Anders A F Sima Hideki Kamiya
Diabetic polyneuropathy (DPN) is a common complication in diabetes. At present, there is no adequate treatment, and DPN is often debilitating for patients. It is a heterogeneous disorder and differs in type 1 and type 2 diabetes. An importa...
Daniel Walcher,Nikolaus Marx Daniel Walcher
Patients with insulin resistance and early type 2 diabetes exhibit an increased sensitivity to develop a diffuse and extensive pattern of arteriosclerosis leading to a remarkable increase in vascular complications, including myocardial infa...
Jaime Haidet,Vincenza Cifarelli,Massimo Trucco et al. Jaime Haidet et al.
C-peptide, historically considered a biologically inactive peptide, has been shown to exert insulin-independent biological effects on a number of cells proving itself as a bioactive peptide with anti-inflammatory properties. Type 1 diabetic...
Thomas Forst,Thomas Hach,Thomas Kunt et al. Thomas Forst et al.
C-Peptide is produced in beta-cells in the pancreas, and secreted into the blood stream in equimolar amounts with insulin. For a long time, C-peptide was considered as an important component in the biosynthesis of insulin, but otherwise bel...
Wathsala Medawala,Patrick McCahill,Adam Giebink et al. Wathsala Medawala et al.
Inspired by previous reports, our group has recently demonstrated that C-peptide exerts beneficial effects upon interactions with red blood cells (RBCs). These effects can be measured in RBCs obtained from animal models of both type 1 diabe...